Stacey Luks

Stacey Luks has an extensive work experience in various accounting roles. Stacey is currently working as the Director of Accounting at Intellia Therapeutics, Inc. since July 2021. Prior to this, they held the positions of Associate Director and Senior Manager of Accounting at the same company from April 2019 to February 2022 and from October 2015 to April 2019 respectively.

Before joining Intellia Therapeutics, Stacey worked as an Accounting Supervisor at Epizyme from May 2014 to October 2015. Prior to that, they were employed at Talbots where they held the roles of Sr. Accounting Analyst, Senior External Reporting Accountant, and Internal Auditor from September 2012 to May 2014, from February 2011 to September 2012, and from August 2008 to February 2011 respectively.

Stacey began their career at PwC as an Experienced Audit Associate from August 2006 to July 2008.

Stacey Luks obtained a Master's and Bachelor's degree in Accounting from SUNY Geneseo, where they studied from 2001 to 2006. Stacey is also a Certified Public Accountant, with certification obtained from the AICPA.